CEO Yehiel Tal highlighted advancements in CollPlant's proprietary photocurable dermal filler, emphasizing its potential as a game-changer in the $6.3 billion market for aesthetic medicine.

Conclusion Facial fillers are a versatile, non-surgical way to rejuvenate your appearance, smooth wrinkles, and restore lost ...